We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

The mRNA vaccines for HIV “are not at all dead in the water,” Kublin told me. If needed, scientists could tweak the vaccine recipe, or combine the mRNA approach with another technology.

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.

Session ID: 2025-07-30:71fc01fb61150f75cab7a56 Player Element ID: vjs_video_3 ...